<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="879">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05149716</url>
  </required_header>
  <id_info>
    <org_study_id>Taurine_aging</org_study_id>
    <nct_id>NCT05149716</nct_id>
  </id_info>
  <brief_title>Taurine as a Possible Anti-aging Therapy?</brief_title>
  <official_title>Taurine as a Possible Anti-aging Therapy? A Controlled Clinical Trial on Taurine Antioxidant Activity in Women Aged 55 to 70 Years</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fundação de Amparo à Pesquisa do Estado de São Paulo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Sao Paulo</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Among the strategies that can improve the body's ability to counteract oxidative stress, the&#xD;
      use of nutritional antioxidants has been investigated. Taurine is a &quot;semi-essential&quot; amino&#xD;
      acid, also called a nitrogen compound, which has been used as an effective antioxidant due to&#xD;
      its ability to neutralize hypochlorous acid, an extremely toxic oxidant produced by&#xD;
      leukocytes in the inflammatory process in humans.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objective: To evaluate the oxidative parameters of women aged 55 to 70 years after 16 weeks&#xD;
      of taurine supplementation.&#xD;
&#xD;
      Methods: Twenty-four women age 55 to 70 will be randomly assigned to two groups: control&#xD;
      group (GC), supplemented with placebo (1.5 g of starch); and taurine group (GTAU),&#xD;
      supplemented with taurine (1.5 g), for 16 weeks. Anthropometry, functional capacity test,&#xD;
      taurine, and levels of oxidative stress markers will be determined in pre and post&#xD;
      intervention plasma samples. Food consumption will be assessed before, during, and after the&#xD;
      intervention. The results will be analyzed by an ANOVA two-way repeated measures mixed model,&#xD;
      with the Sidak post hoc (p &lt; 0.05).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 13, 2020</start_date>
  <completion_date type="Actual">July 3, 2020</completion_date>
  <primary_completion_date type="Actual">June 15, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Double-blind placebo controlled study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
    <masking_description>Supplement capsule packages were labeled as &quot;Supplement A&quot; and &quot;Supplement B&quot; and the nutrient (taurine or placebo- starch) was revealed after the end of the intervention.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in blood oxidative stress marker measurement - Superoxide Dismutase (SOD).</measure>
    <time_frame>sixteen weeks</time_frame>
    <description>The superoxide dismutase (SOD) activity in erythrocytes was evaluated by the spectrophotometric method, and were calculated at 16 weeks in comparision to the baseline.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in blood oxidative stress marker measurement - Glutathione reductase (GR).</measure>
    <time_frame>sixteen weeks</time_frame>
    <description>Glutathione reductase (GR) activity was determined by the spectrophotometric method at 37 ºC/340nm after the oxidation of NADPH in the presence of oxidized glutathione, and were calculated at 16 weeks in comparision to the baseline.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in blood oxidative stress marker measurement - Malondialdehyde (MDA).</measure>
    <time_frame>sixteen weeks</time_frame>
    <description>The malondialdehyde (MDA) were calculated at 16 weeks in comparision to the baseline.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Oxidative Stress</condition>
  <arm_group>
    <arm_group_label>Taurine supplementation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Taurine supplementation composed of capsules of taurine powder. Dosage: 1.5 gram/day Frequency: 1 time/day Duration: 16 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo supplementation</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo supplementation composed of capsules of starch powder. Dosage: 1.5 gram/day Frequency: 1 time/day Duration: 16 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Taurine</intervention_name>
    <description>Taurine supplementation in capsules of 500 grams of taurine powder, total dosage: 1.5 gram/day</description>
    <arm_group_label>Taurine supplementation</arm_group_label>
    <other_name>Taurine supplementation in capsules of 500 grams of taurine powder, total dosage: 1.5 grams/day</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo supplementation in capsules of 500 grams of starch powder, total dosage: 1.5 gram/day</description>
    <arm_group_label>Placebo supplementation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Had being aged 55-70 years;&#xD;
&#xD;
          -  Female;&#xD;
&#xD;
          -  Post-menopausal;&#xD;
&#xD;
          -  Sedentary (not practicing physical exercise for at least 6 months).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Chronic kidney diseases;&#xD;
&#xD;
          -  Infectious contagious diseases;&#xD;
&#xD;
          -  Coronary heart disease;&#xD;
&#xD;
          -  Smokers&#xD;
&#xD;
          -  Alcoholics.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ellen C Freitas, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Sao Paulo</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Escola de Educação Física e Esporte de Ribeirão Preto</name>
      <address>
        <city>Ribeirao Preto</city>
        <state>Sao Paulo</state>
        <zip>14040-907</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <reference>
    <citation>Schaffer S, Kim HW. Effects and Mechanisms of Taurine as a Therapeutic Agent. Biomol Ther (Seoul). 2018 May 1;26(3):225-241. doi: 10.4062/biomolther.2017.251. Review.</citation>
    <PMID>29631391</PMID>
  </reference>
  <reference>
    <citation>Tadolini B, Pintus G, Pinna GG, Bennardini F, Franconi F. Effects of taurine and hypotaurine on lipid peroxidation. Biochem Biophys Res Commun. 1995 Aug 24;213(3):820-6.</citation>
    <PMID>7654243</PMID>
  </reference>
  <reference>
    <citation>Oliveira MW, Minotto JB, de Oliveira MR, Zanotto-Filho A, Behr GA, Rocha RF, Moreira JC, Klamt F. Scavenging and antioxidant potential of physiological taurine concentrations against different reactive oxygen/nitrogen species. Pharmacol Rep. 2010 Jan-Feb;62(1):185-93.</citation>
    <PMID>20360629</PMID>
  </reference>
  <reference>
    <citation>Lourenço R, Camilo ME. Taurine: a conditionally essential amino acid in humans? An overview in health and disease. Nutr Hosp. 2002 Nov-Dec;17(6):262-70. Review.</citation>
    <PMID>12514918</PMID>
  </reference>
  <reference>
    <citation>Sun Jang J, Piao S, Cha YN, Kim C. Taurine Chloramine Activates Nrf2, Increases HO-1 Expression and Protects Cells from Death Caused by Hydrogen Peroxide. J Clin Biochem Nutr. 2009 Jul;45(1):37-43. doi: 10.3164/jcbn.08-262. Epub 2009 Jun 30.</citation>
    <PMID>19590705</PMID>
  </reference>
  <reference>
    <citation>Rosa FT, Freitas EC, Deminice R, Jordão AA, Marchini JS. Oxidative stress and inflammation in obesity after taurine supplementation: a double-blind, placebo-controlled study. Eur J Nutr. 2014 Apr;53(3):823-30. doi: 10.1007/s00394-013-0586-7. Epub 2013 Sep 25.</citation>
    <PMID>24065043</PMID>
  </reference>
  <reference>
    <citation>De Carvalho FG, Galan BSM, Santos PC, Pritchett K, Pfrimer K, Ferriolli E, Papoti M, Marchini JS, de Freitas EC. Taurine: A Potential Ergogenic Aid for Preventing Muscle Damage and Protein Catabolism and Decreasing Oxidative Stress Produced by Endurance Exercise. Front Physiol. 2017 Sep 20;8:710. doi: 10.3389/fphys.2017.00710. eCollection 2017.</citation>
    <PMID>28979213</PMID>
  </reference>
  <reference>
    <citation>Chupel MU, Minuzzi LG, Furtado GE, Santos ML, Ferreira JP, Filaire E, Teixeira AM. Taurine supplementation reduces myeloperoxidase and matrix-metalloproteinase-9 levels and improves the effects of exercise in cognition and physical fitness in older women. Amino Acids. 2021 Mar;53(3):333-345. doi: 10.1007/s00726-021-02952-6. Epub 2021 Feb 13.</citation>
    <PMID>33586039</PMID>
  </reference>
  <results_reference>
    <citation>Marcinkiewicz J, Kontny E. Taurine and inflammatory diseases. Amino Acids. 2014 Jan;46(1):7-20. doi: 10.1007/s00726-012-1361-4. Epub 2012 Jul 19. Review.</citation>
    <PMID>22810731</PMID>
  </results_reference>
  <verification_date>December 2021</verification_date>
  <study_first_submitted>November 19, 2021</study_first_submitted>
  <study_first_submitted_qc>December 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 8, 2021</study_first_posted>
  <last_update_submitted>December 2, 2021</last_update_submitted>
  <last_update_submitted_qc>December 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Sao Paulo</investigator_affiliation>
    <investigator_full_name>Ellen Cristini de Freitas</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Aging</keyword>
  <keyword>Oxidative Stress</keyword>
  <keyword>Taurine</keyword>
  <keyword>Nutritional Supplementation</keyword>
  <keyword>Therapeutic Strategy</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

